| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |